Jacobs Levy Equity Management’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-878,955
| Closed | -$2.05M | – | 945 |
|
|
2024
Q2 | $2.05M | Buy |
+878,955
| New | +$2.05M | 0.01% | 592 |
|
|
2023
Q1 | – | Sell |
-11,217
| Closed | -$70.6K | – | 952 |
|
|
2022
Q4 | $70.6K | Sell |
11,217
-524,151
| -98% | -$3.3M | ﹤0.01% | 930 |
|
|
2022
Q3 | $5.78M | Buy |
+535,368
| New | +$5.78M | 0.05% | 360 |
|
|
2022
Q2 | – | Sell |
-270,737
| Closed | -$2.47M | – | 992 |
|
|
2022
Q1 | $2.47M | Buy |
+270,737
| New | +$2.47M | 0.02% | 588 |
|